Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer

Figure 2 Forest plot of univariate competing risk survival models. Colorectal cancer-specific hazard was higher if a patient had a lower lymphocyte-to-monocyte ratio, hemoglobin-to-platelet ratio, or platelet-to-lymphocyte ratio and higher neutrophil-to-lymphocyte ratio or personalized platelet count relative to “at-diagnosis”. Red blood cell distribution width-to-platelet ratio did not affect neither pre- nor post-operative survival. CI: Confidence interval; HR: Hazard ratio; LMR: Lymphocyte-to-monocyte ratio; PLR: Platelet-to-lymphocyte ratio; NLR: Neutrophil-to-lymphocyte ratio; HPR: hemoglobin-to-platelet ratio; RPR: red blood cell distribution width-to-platelet ratio; pPLT_D: Personalized platelet count relative to “at-diagnosis”.